Partnership with ORx Pharmaceutical
Strategic Alliances
ORx’s business strategy is to develop strategic alliances with pharmaceutical and biotechnology companies that have marketed products or drugs in development that would benefit from ORx technologies.
ORx Pharmaceuticals promotes the following partnership and collaboration options:
Product Licensing of Superior ORx Products:
ORx has developed several products with supporting pre clinical and clinical data proffering significant clinical improvements of established market drugs. The development modality of these products minimizes regulatory requirements thus allowing new product approval and commercialization in a relatively short period of time; typically within 24-36 months from initiation.
Drug Product Feasibility With An Option To License:
Through establishing a development feasibility contract with ORx, challenging compound(s) can undergo fast and highly cost effective formulation screening process for development stage compounds. This will provide product strategies to overcome issues presented with highly soluble, poorly absorbed compounds.
Co-Development of NCE Proprietary Products:
Collaboration with ORx on new chemical compounds will assist with life cycle management of existing proprietary compounds and promising NCEs.